Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Jun;74(6):715–719. doi: 10.1136/jnnp.74.6.715

Alzheimer's disease: differences in technetium-99m HMPAO SPECT scan findings between early onset and late onset dementia

P Kemp 1, C Holmes 1, S Hoffmann 1, L Bolt 1, R Holmes 1, J Rowden 1, J Fleming 1
PMCID: PMC1738480  PMID: 12754337

Abstract

Objective: To compare the HMPAO SPECT cerebral perfusion patterns in early and late onset Alzheimer's disease.

Methods: Twenty patients with early onset disease (<65 years) and 44 patients with late onset disease (>65 years) were studied. All patients fulfilled NINCDS-ADRDA clinical criteria and had details of disease severity and length of history at the time of imaging. Technetium-99m HMPAO SPECT brain scans were acquired on a multi-detector gammacamera and analysed visually and with statistical parametric mapping (SPM99).

Results: Patients with early onset disease had significantly greater posterior cortical association area involvement whereas those with late onset disease had significantly greater medial temporal hypoperfusion. These findings were unchanged after controlling for disease severity and length of illness.

Discussion: These functional imaging findings of the differences between early and late onset Alzheimer's disease are supported by published findings that include histopathological and clinical evidence; namely late onset patients tend to present with the characteristic involvement of the medial temporal lobes producing marked memory loss whereas early onset patients present with predominant posterior cortical association area involvement. These age related findings should be borne in mind when clinically diagnosing, and interpreting functional brain imaging studies in, patients with suspected Alzheimer's disease.

Full Text

The Full Text of this article is available as a PDF (198.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball J. A., Lantos P. L., Jackson M., Marsden C. D., Scadding J. W., Rossor M. N. Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry. 1993 Sep;56(9):1020–1023. doi: 10.1136/jnnp.56.9.1020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berthier M. L., Leiguarda R., Starkstein S. E., Sevlever G., Taratuto A. L. Alzheimer's disease in a patient with posterior cortical atrophy. J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1110–1111. doi: 10.1136/jnnp.54.12.1110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259. doi: 10.1007/BF00308809. [DOI] [PubMed] [Google Scholar]
  4. Cogan D. G. Visual disturbances with focal progressive dementing disease. Am J Ophthalmol. 1985 Jul 15;100(1):68–72. doi: 10.1016/s0002-9394(14)74985-2. [DOI] [PubMed] [Google Scholar]
  5. Colloby Sean J., Fenwick John D., Williams E. David, Paling Sean M., Lobotesis Kyriakos, Ballard Clive, McKeith Ian, O'Brien John T. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging. 2002 Mar 5;29(5):615–622. doi: 10.1007/s00259-002-0778-5. [DOI] [PubMed] [Google Scholar]
  6. Friston K. J. Commentary and opinion: II. Statistical parametric mapping: ontology and current issues. J Cereb Blood Flow Metab. 1995 May;15(3):361–370. doi: 10.1038/jcbfm.1995.45. [DOI] [PubMed] [Google Scholar]
  7. Galton C. J., Patterson K., Xuereb J. H., Hodges J. R. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain. 2000 Mar;123(Pt 3):484–498. doi: 10.1093/brain/123.3.484. [DOI] [PubMed] [Google Scholar]
  8. Grady C. L., Haxby J. V., Horwitz B., Berg G., Rapoport S. I. Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia. 1987;25(5):807–816. doi: 10.1016/0028-3932(87)90118-7. [DOI] [PubMed] [Google Scholar]
  9. Green J., Morris J. C., Sandson J., McKeel D. W., Jr, Miller J. W. Progressive aphasia: a precursor of global dementia? Neurology. 1990 Mar;40(3 Pt 1):423–429. doi: 10.1212/wnl.40.3_part_1.423. [DOI] [PubMed] [Google Scholar]
  10. Greene J. D., Patterson K., Xuereb J., Hodges J. R. Alzheimer disease and nonfluent progressive aphasia. Arch Neurol. 1996 Oct;53(10):1072–1078. doi: 10.1001/archneur.1996.00550100158027. [DOI] [PubMed] [Google Scholar]
  11. Greicius M. D., Geschwind M. D., Miller B. L. Presenile dementia syndromes: an update on taxonomy and diagnosis. J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):691–700. doi: 10.1136/jnnp.72.6.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jobst K. A., Barnetson L. P., Shepstone B. J. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Int Psychogeriatr. 1998 Sep;10(3):271–302. doi: 10.1017/s1041610298005389. [DOI] [PubMed] [Google Scholar]
  13. Kobayashi S., Hirota N., Saito K., Utsuyama M. Aluminum accumulation in tangle-bearing neurons of Alzheimer's disease with Balint's syndrome in a long-term aluminum refiner. Acta Neuropathol. 1987;74(1):47–52. doi: 10.1007/BF00688337. [DOI] [PubMed] [Google Scholar]
  14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  15. Nitrini R., Buchpiguel C. A., Caramelli P., Bahia V. S., Mathias S. C., Nascimento C. M., Degenszajn J., Caixeta L. SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion. Acta Neurol Scand. 2000 Mar;101(3):172–176. doi: 10.1034/j.1600-0404.2000.101003172.x. [DOI] [PubMed] [Google Scholar]
  16. O'Brien J. T., Ballard C. G. Drugs for Alzheimer's disease. BMJ. 2001 Jul 21;323(7305):123–124. doi: 10.1136/bmj.323.7305.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. O'Brien J. T., Eagger S., Syed G. M., Sahakian B. J., Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1182–1187. doi: 10.1136/jnnp.55.12.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pogacar S., Williams R. S. Alzheimer's disease presenting as slowly progressive aphasia. R I Med J. 1984 Apr;67(4):181–185. [PubMed] [Google Scholar]
  19. Ross S. J., Graham N., Stuart-Green L., Prins M., Xuereb J., Patterson K., Hodges J. R. Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):388–395. doi: 10.1136/jnnp.61.4.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sakamoto Setsu, Ishii Kazunari, Sasaki Masahiro, Hosaka Kayo, Mori Tetsuya, Matsui Mieko, Hirono Nobutsugu, Mori Etsuro. Differences in cerebral metabolic impairment between early and late onset types of Alzheimer's disease. J Neurol Sci. 2002 Aug 15;200(1-2):27–32. doi: 10.1016/s0022-510x(02)00114-4. [DOI] [PubMed] [Google Scholar]
  21. Victoroff J., Ross G. W., Benson D. F., Verity M. A., Vinters H. V. Posterior cortical atrophy. Neuropathologic correlations. Arch Neurol. 1994 Mar;51(3):269–274. doi: 10.1001/archneur.1994.00540150063018. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES